CorTec’s CEO Says FDA Breakthrough Marks Shift To Therapeutic BCI For Stroke

 Can't see this all of this since I'm not in business anymore. But if this is reading signals from the motor cortex it won't help persons like me whose motor cortex is dead.

CorTec’s CEO Says FDA Breakthrough Marks Shift To Therapeutic BCI For Stroke

 CorTec secured US FDA breakthrough device designation for an implantable BCI that restores motor function in stroke patients. With the device implanted in two patients and a third to come, CorTec now eyes larger trials and a $40m-$50m funding raise.

Germany-based CorTec GmbH has received US FDA beakthrough device designation for its brain-computer interface (BCI) system designed to restore motor function in stroke patients.

Germany-based CorTec GmbH has received US Food and Drug Administration breakthrough device designation for its brain-computer interface (BCI) system designed to restore motor function in stroke patients.

Key Takeaways

• CorTec received FDA breakthrough device designation, which CEO Frank Desiere considers a major milestone for therapeutic BCIs.

CorTec CEO Frank Desiere considers the FDA designation a major milestone for the company and the broader BCI field, where...